SIGNIFOR 30 mg, powder and solvent for injectable suspension bottle, 2 ml
Active ingredients: Pasireotide pamoate, Pasireotide
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for injectable suspensionbottle, 2 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SIGNIFOR 30 mg, poudre et solvant pour suspension injectable
- Pharmaceutical form
- poudre et solvant pour suspension injectable
- Route of administration
- intramusculaire
- Presentation description
- 1 flacon(s) brun en verre de 30 mg - 1 seringue(s) préremplie(s) en verre de 2 ml avec adaptateur(s) pour flacon avec aiguille(s) sécurisée(s)
- Marketing authorisation holder
- RECORDATI RARE DISEASES
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Feb 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69935063CIP73011740CIP133400930117408Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PAMOATE DE PASIRÉOTIDEpoudre | — | SA |
| PASIRÉOTIDEpoudre | 30 mg · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.